Additional file 1: of Bapineuzumab for mild to moderate Alzheimerâs disease: a meta-analysis of randomized controlled trials
- Publication date
- Publisher
Abstract
Shows the reasons for exclusion of retrieved articles during full text screening. (DOCX 31Â kb